Investors
Major shareholders
As at 31 May 2022
Abcam plc is both the UK operating company and the holding company for the group. There are a number of trading subsidiaries, which are 100 per cent owned by Abcam plc; a full list can be found in the annual report which can be downloaded here.
The Company’s issued share capital at the above date was 228,946,389 ordinary shares of 0.2 pence each. The percentage of shares not held in public hands (as defined by AIM rule 26) was 0.6%. The Company has no treasury shares, and there are no restrictions on transfers of ordinary shares.
Shareholders with more than 3% holding (as at 31 May 2022) were:
| Shareholder | Total Interest | % issued shared capital |
|---|---|---|
| T. Rowe Price Group | 20,407,665 | 8.91% |
| Wellington Management Company | 15,530,446 | 6.78% |
| Milner Dr J S | 15,520,820 | 6.78% |
| Durable Capital Partners, L.P. | 15,513,364 | 6.78% |
| Baillie Gifford & Co Ltd | 12,976,670 | 5.67% |
| Harding Loevner LLC | 11,936,383 | 5.21% |
| Wasatch Advisors Inc | 8,604,067 | 3.76% |
| Brown Capital Management Inc | 8,527,207 | 3.72% |
Discovery Drive, Cambridge
Biomedical Campus,
Cambridge, CB2 0AX, UK
+44 (0) 1223 696 000
VIEW PRODUCTS
abcam.comabcam.co.jp
abcam.cn
© Abcam plc. all rights reserved.
Abcam plc is incorporated in England and Wales, its main country of operation in the UK. Use of this website is subject to our Terms and Conditions of use and our Privacy Policy. Share price and news information on this site is updated dynamically from external data feeds.
Website by FisherPaul